Natural Biocon

  • Market Cap: Micro Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE06MM01016
  • NSEID:
  • BSEID: 543207
INR
3.80
-0.07 (-1.81%)
BSENSE

May 06

BSE+NSE Vol: 20.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002523,
    "name": "Natural Biocon",
    "stock_name": "Natural Biocon",
    "full_name": "Natural Biocon (India) Ltd",
    "name_url": "stocks-analysis/natural-biocon",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.80",
    "chg": -0.07,
    "chgp": "-1.81%",
    "dir": -1,
    "prev_price": "3.87",
    "mcapval": "10.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543207,
    "symbol": "",
    "ind_name": "Pesticides & Agrochemicals",
    "ind_code": 67,
    "indexname": "India SENSEX",
    "isin": "INE06MM01016",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "20.22 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natural-biocon-1002523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Natural Biocon (India) Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-natural-biocon-india-ltd-3959899",
        "imagepath": "",
        "date": "2026-04-23 23:16:30",
        "description": "Natural Biocon (India) Ltd is scheduled to declare its results on April 30, 2026...."
      },
      {
        "title": "When is the next results date for Natural Biocon (India) Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-natural-biocon-india-ltd-3831920",
        "imagepath": "",
        "date": "2026-02-10 23:18:30",
        "description": "Natural Biocon (India) Ltd is scheduled to declare its results on 13 February 2026...."
      }
    ],
    "total": 16,
    "sid": "1002523",
    "stock_news_url": "https://www.marketsmojo.com/news/natural-biocon-india-1002523"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Audited Results And Audit Report",
      "datetime": "30-Apr-2026",
      "details": "Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2026 inter alia to consider and approve Audited Results and Audit Report",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "28-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Natural Biocon (India) Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24299GJ1992PLC018210</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Gopal Trivedi <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: naturalbioconindia@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Arunkumar Prajapati <br/> Designation: Chief Financial Officer <br/> EmailId: naturalbioconindia@gmail.com</div> </div> <div> <br/> Date: 28/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March 2026 Along With The Auditors Report.",
      "datetime": "22-Apr-2026",
      "details": "Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 inter alia to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on 31st March 2026 along with the Auditors Report.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "09 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Intimation for Audited Results And Audit Report

30-Apr-2026 | Source : BSE

Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2026 inter alia to consider and approve Audited Results and Audit Report

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

28-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyNatural Biocon (India) Ltd
2CIN NO.L24299GJ1992PLC018210
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Gopal Trivedi
Designation: Company Secretary and Compliance Officer
EmailId: naturalbioconindia@gmail.com
Name of the Chief Financial Officer: Arunkumar Prajapati
Designation: Chief Financial Officer
EmailId: naturalbioconindia@gmail.com

Date: 28/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March 2026 Along With The Auditors Report.

22-Apr-2026 | Source : BSE

Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 inter alia to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on 31st March 2026 along with the Auditors Report.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

09 May 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available